Goldfarb Seligman

Goldfarb Gross Seligman is a large Israeli full-service law firm, not a biotech, pharma, or healthcare operating company. The firm provides legal services across corporate, M&A, capital markets, intellectual property, litigation, tax, finance, and regulatory matters, and it maintains a dedicated life sciences practice serving medtech, biotech, healthcare, and pharmaceutical clients. The current firm was formed through a 2023 merger between Goldfarb Seligman and Gross & Co., building on predecessor firms with roots dating back to 1930. Its life sciences work appears focused on legal counsel for transactions, regulation, intellectual property, clinical-trial-related matters, and commercial agreements rather than developing therapeutic products.